tirzepatide gip/glp-1 drops is a first-in-class dual agonist targeting both GIP and GLP-1 and Dual GIP/GLP-1 Agonists

This shift from subcutaneous fat (under the skin) to visceral fat (around organs) is what creates the menopause belly or menopot that so many women describe

Davidson JA, Brett J, Falahati A, Scott D

How to slow weight regain When you lose weight, your body naturally fights against it by suppressing how many calories you burn and increasing your hunger drive, West said

Behavioral parameters included the number of rearings (vertical exploratory movements) (Fig

As with all GLP-1based therapies, individual outcomes vary depending on adherence, baseline metabolic health, dose optimisation, and lifestyle support

Lifestyle factors: I walk daily (1012k steps, half of which is a dedicated walk)